Stock SUNZEN SUNZEN BIOTECH
Add to a list
To use this feature you must be a member
Log inSign up

Sunzen Biotech Stock

Equities

SUNZEN

MYQ0148OO005

Food Processing

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
0.365 MYR -3.95% Intraday chart for Sunzen Biotech -3.95% +21.67%
May. 24 Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter Ended March 31, 2024 CI
May. 06 Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million CI

Financials

Sales 2021 90.48M 19.16M Sales 2022 97.09M 20.56M Capitalization 141M 29.84M
Net income 2021 - 0 Net income 2022 3M 635K EV / Sales 2021 1.49 x
Net cash position 2021 41.96M 8.89M Net cash position 2022 6.98M 1.48M EV / Sales 2022 1.38 x
P/E ratio 2021
227 x
P/E ratio 2022
42.6 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 30.39%
More Fundamentals * Assessed data

Chart Sunzen Biotech

Dynamic Chart

Latest news about Sunzen Biotech

Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter Ended March 31, 2024 CI
Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million CI
Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International MT
Sunzen Biotech to End Operations of Loss-Making Animal Health Unit MT
Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sunzen Biotech Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Sunzen Biotech Buys MYR4.3 Million Stake in Farmer International MT
Sunzen Biotech Berhad agreed to acquire additional 30% stake in Ecolite Biotech Manufacturing Sdn Bhd from group of sellers for MYR 18.2 million. CI
Sunzen Biotech Berhad Announces Change of Address CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Member of Audit Committee CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Nomination Committee CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Independent Director CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Remuneration Committee CI
Sunzen Biotech Berhad Announces Change in Financial Year End CI
Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news

Quotes and Performance

1 day-3.95%
1 week-3.95%
Current month-3.95%
3 months+17.74%
6 months+25.86%
Current year+21.67%
More quotes

Highs and lows

1 week
0.36
Extreme 0.36
0.39
1 month
0.34
Extreme 0.335
0.40
Current year
0.22
Extreme 0.22
0.40
1 year
0.19
Extreme 0.19
0.40
3 years
0.18
Extreme 0.18
0.40
5 years
0.03
Extreme 0.03
0.40
10 years
0.03
Extreme 0.03
0.54
More quotes

Managers and Directors - Sunzen Biotech

Managers TitleAgeSince
Yek Ming Teo CEO
 Chief Executive Officer 41 20-06-15
Tong Eng Phang DFI
 Director of Finance/CFO 61 08-02-11
Weng Soon Cheng SEC
 Corporate Secretary - Nov. 28
Members of the board TitleAgeSince
Yew Weng Lee BRD
 Director/Board Member 47 20-07-31
Kien Hoe Khoo BRD
 Director/Board Member 53 14-07-21
Yek Ming Teo CEO
 Chief Executive Officer 41 20-06-15
More insiders

Quotes

Date Price Change Volume
24-06-10 0.365 -3.95% 2,009,900
24-06-07 0.38 +1.33% 2,000,400
24-06-06 0.375 -1.32% 4,429,700
24-06-05 0.38 -1.30% 1,709,500

End-of-day quote BURSA MALAYSIA, June 09, 2024

More quotes

Company Profile

Sunzen Biotech Berhad is a Malaysia-based company, which is principally engaged in the businesses of biotechnology research and development, manufacturing and marketing of animal feed supplement products and investment holding. The Company operates through four segments: Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Loan financing. Its products include bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, Bai Foong Wan, food supplements, dried herbs and more. The products are widely distributed to all consumers through retail concept stores in Malaysia as well in Ecolite store online shop. Its subsidiaries include Sunzen Corporation Sdn. Bhd., Sunzen International Sdn. Bhd., Finsource Credit (M) Sdn. Bhd., and Sunzen Lifesciences Sdn. Bhd among others.
Sector
Food Processing
Calendar
2024-08-26 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

1st Jan change Capi.
SUNZEN BIOTECH Stock Sunzen Biotech
+21.67% 57.47M
NESTLÉ S.A. Stock Nestlé S.A.
-1.96% 287B
MONDELEZ INTERNATIONAL, INC. Stock Mondelez International, Inc.
-7.08% 90.96B
KRAFT HEINZ Stock Kraft Heinz
-9.28% 41.76B
DANONE Stock Danone
+1.12% 41.74B
THE HERSHEY COMPANY Stock The Hershey Company
+2.51% 39.65B
GENERAL MILLS, INC. Stock General Mills, Inc.
+2.70% 38.08B
ARCHER-DANIELS-MIDLAND COMPANY Stock Archer-Daniels-Midland Company
-14.22% 30.29B
NESTLÉ INDIA LIMITED Stock Nestlé India Limited
-3.64% 28.91B
ASSOCIATED BRITISH FOODS PLC Stock Associated British Foods plc
+7.56% 24.27B
Other Food Processing
  1. Stock Market
  2. Equities
  3. SUNZEN Stock